Preliminary findings suggest an artificial intelligence-designed compound may hold promise in decelerating biological aging, offering a potential breakthrough in longevity research. Scientists have identified a molecule created through AI-driven screening that appears to interact with key aging-related pathways in human cells. While still in the experimental phase, the discovery raises hopes for new therapeutic approaches to age-related diseases. Researchers emphasize that further testing is needed before any conclusions can be drawn about its safety or efficacy in humans.
Early Data Indicates an A.I.-Generated Drug Could Slow Aging nytimes.com
